(RPD) Rapid7 - Overview
Stock: Cybersecurity, Vulnerability, Detection, Response, Automation, Cloud
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 46.1% |
| Relative Tail Risk | -10.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -2.46 |
| Alpha | -89.96 |
| Character TTM | |
|---|---|
| Beta | 1.159 |
| Beta Downside | 1.261 |
| Drawdowns 3y | |
|---|---|
| Max DD | 82.90% |
| CAGR/Max DD | -0.49 |
Description: RPD Rapid7 January 17, 2026
Rapid7, Inc. (NASDAQ:RPD) delivers a portfolio of cybersecurity software and services under the Rapid7, Nexpose, and Metasploit brands. Core products include the Insight Agent for asset telemetry, Insight Network Sensor for full-packet network visibility, and Cloud Event Data Harvesting for real-time monitoring of cloud-resource changes. The company also bundles these data sources into managed and integrated solutions such as Managed Threat Complete (MDR), Threat Complete (SIEM/XDR via InsightIDR), Exposure Command (attack-surface management), Surface Command (asset-to-cloud risk prioritization), Vector Command (continuous external red-team testing), InsightCloudSec (cloud compliance), InsightAppSec (dynamic application testing), and InsightVM (vulnerability management). Professional services round out the offering with advisory, incident response, and day-to-day operational support.
From a market perspective, Rapid7’s FY 2024 revenue grew ~12% YoY to roughly $800 million, driven largely by a 30% increase in subscription ARR from its Insight platform-a key KPI for SaaS-based security vendors. The broader cybersecurity software sector is expanding at a 9-10% compound annual growth rate, underpinned by rising cloud adoption and heightened regulatory pressure (e.g., GDPR, CCPA). A material economic driver for Rapid7 is the shift from on-premise point solutions to integrated XDR and attack-surface management suites, which tend to generate higher multi-year contract values and lower churn.
For analysts seeking a deeper comparative view of Rapid7’s valuation relative to peers, a quick look at ValueRay’s platform can surface granular metric breakdowns and scenario analyses-worth a glance before finalizing any investment thesis.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 18.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA -0.66 > 1.0 |
| NWC/Revenue: 11.65% < 20% (prev 11.88%; Δ -0.24% < -1%) |
| CFO/TA 0.11 > 3% & CFO 179.6m > Net Income 18.8m |
| Net Debt (840.2m) to EBITDA (82.8m): 10.14 < 3 |
| Current Ratio: 1.19 > 1.5 & < 3 |
| Outstanding Shares: last quarter (65.2m) vs 12m ago -12.55% < -2% |
| Gross Margin: 70.21% > 18% (prev 0.71%; Δ 6951 % > 0.5%) |
| Asset Turnover: 52.99% > 50% (prev 52.91%; Δ 0.08% > 0%) |
| Interest Coverage Ratio: 3.49 > 6 (EBITDA TTM 82.8m / Interest Expense TTM 10.6m) |
Altman Z'' -2.00
| A: 0.06 (Total Current Assets 635.0m - Total Current Liabilities 535.0m) / Total Assets 1.67b |
| B: -0.58 (Retained Earnings -967.8m / Total Assets 1.67b) |
| C: 0.02 (EBIT TTM 37.1m / Avg Total Assets 1.62b) |
| D: -0.63 (Book Value of Equity -964.7m / Total Liabilities 1.54b) |
| Altman-Z'' Score: -2.00 = D |
Beneish M -3.07
| DSRI: 0.97 (Receivables 141.3m/141.9m, Revenue 858.7m/833.0m) |
| GMI: 1.01 (GM 70.21% / 70.62%) |
| AQI: 1.10 (AQ_t 0.57 / AQ_t-1 0.52) |
| SGI: 1.03 (Revenue 858.7m / 833.0m) |
| TATA: -0.10 (NI 18.8m - CFO 179.6m) / TA 1.67b) |
| Beneish M-Score: -3.07 (Cap -4..+1) = AA |
What is the price of RPD shares?
Over the past week, the price has changed by -9.31%, over one month by -24.72%, over three months by -24.93% and over the past year by -71.75%.
Is RPD a buy, sell or hold?
- StrongBuy: 6
- Buy: 3
- Hold: 15
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the RPD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 18 | 66.7% |
| Analysts Target Price | 18 | 66.7% |
| ValueRay Target Price | 6.3 | -42.1% |
RPD Fundamental Data Overview February 05, 2026
P/E Forward = 5.5991
P/S = 0.8129
P/B = 6.0737
P/EG = 0.2179
Revenue TTM = 858.7m USD
EBIT TTM = 37.1m USD
EBITDA TTM = 82.8m USD
Long Term Debt = 891.3m USD (from longTermDebt, last quarter)
Short Term Debt = 16.0m USD (from shortTermDebt, last quarter)
Debt = 970.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 840.2m USD (from netDebt column, last quarter)
Enterprise Value = 1.26b USD (698.0m + Debt 970.8m - CCE 407.1m)
Interest Coverage Ratio = 3.49 (Ebit TTM 37.1m / Interest Expense TTM 10.6m)
EV/FCF = 7.52x (Enterprise Value 1.26b / FCF TTM 167.7m)
FCF Yield = 13.29% (FCF TTM 167.7m / Enterprise Value 1.26b)
FCF Margin = 19.53% (FCF TTM 167.7m / Revenue TTM 858.7m)
Net Margin = 2.19% (Net Income TTM 18.8m / Revenue TTM 858.7m)
Gross Margin = 70.21% ((Revenue TTM 858.7m - Cost of Revenue TTM 255.8m) / Revenue TTM)
Gross Margin QoQ = 69.27% (prev 70.56%)
Tobins Q-Ratio = 0.76 (Enterprise Value 1.26b / Total Assets 1.67b)
Interest Expense / Debt = 0.27% (Interest Expense 2.58m / Debt 970.8m)
Taxrate = 38.42% (15.9m / 41.5m)
NOPAT = 22.9m (EBIT 37.1m * (1 - 38.42%))
Current Ratio = 1.19 (Total Current Assets 635.0m / Total Current Liabilities 535.0m)
Debt / Equity = 7.63 (Debt 970.8m / totalStockholderEquity, last quarter 127.2m)
Debt / EBITDA = 10.14 (Net Debt 840.2m / EBITDA 82.8m)
Debt / FCF = 5.01 (Net Debt 840.2m / FCF TTM 167.7m)
Total Stockholder Equity = 72.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.16% (Net Income 18.8m / Total Assets 1.67b)
RoE = 26.06% (Net Income TTM 18.8m / Total Stockholder Equity 72.0m)
RoCE = 3.86% (EBIT 37.1m / Capital Employed (Equity 72.0m + L.T.Debt 891.3m))
RoIC = 2.32% (NOPAT 22.9m / Invested Capital 984.8m)
WACC = 4.36% (E(698.0m)/V(1.67b) * Re(10.19%) + D(970.8m)/V(1.67b) * Rd(0.27%) * (1-Tc(0.38)))
Discount Rate = 10.19% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -5.97%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈168.1m ; Y1≈207.4m ; Y5≈353.2m
Fair Price DCF = 144.2 (EV 10.28b - Net Debt 840.2m = Equity 9.44b / Shares 65.5m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 84.71 | EPS CAGR: 109.6% | SUE: 1.30 | # QB: 3
Revenue Correlation: 94.26 | Revenue CAGR: 10.16% | SUE: 1.10 | # QB: 6
EPS next Quarter (2026-03-31): EPS=0.47 | Chg30d=-0.014 | Revisions Net=-3 | Analysts=20
EPS next Year (2026-12-31): EPS=1.98 | Chg30d=-0.017 | Revisions Net=-4 | Growth EPS=-3.5% | Growth Revenue=+1.5%